NEIL KUMAR - 16 Feb 2026 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: Chief Executive Officer, Director
Signature: /s/ Will Solis, Attorney-in-Fact
Issuer symbol: BBIO
Transactions as of: 16 Feb 2026
Net transactions value: -$2,330,492
Form type: 4
Filing time: 18 Feb 2026, 18:41:47 UTC
Previous filing: 12 Feb 2026
Next filing: 23 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kumar Neil	Chief Executive Officer, Director	C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO	/s/ Will Solis, Attorney-in-Fact	18 Feb 2026	0001742485

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBIO	Common Stock	Options Exercise		+33,544	+15%		262,320	16 Feb 2026	Direct	F1
transaction	BBIO	Common Stock	Options Exercise		+19,600	+7.5%		281,920	16 Feb 2026	Direct	F1
transaction	BBIO	Common Stock	Options Exercise		+11,554	+4.1%		293,474	16 Feb 2026	Direct	F1
transaction	BBIO	Common Stock	Tax liability	$2,330,492	-30,970	-11%	$75.25	262,504	16 Feb 2026	Direct	F2
holding	BBIO	Common Stock						675,686	16 Feb 2026	By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.	F3
holding	BBIO	Common Stock						4,478,447	16 Feb 2026	By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-33,544	-20%	$0.000000	134,176	16 Feb 2026	Common Stock	33,544		Direct	F1, F4
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-19,600	-11%	$0.000000	156,794	16 Feb 2026	Common Stock	19,600		Direct	F1, F5
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-11,554	-7.7%	$0.000000	138,645	16 Feb 2026	Common Stock	11,554		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 64,698 shares of Common Stock underlying the Reporting Person's RSUs.
F3	The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4	The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F5	The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F6	The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.